Citadel Advisors’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Buy
528,970
+273,260
+107% +$7.58M ﹤0.01% 2921
2025
Q4
$7.09M Buy
+255,710
New +$6.52M ﹤0.01% 3743
2025
Q3
Sell
-2,337,517
Closed -$46.5M 12767
2025
Q2
$39.8M Sell
2,337,517
-162,830
-7% -$2.84M 0.01% 1420
2025
Q1
$48.8M Buy
2,500,347
+438,101
+21% +$11.5M 0.01% 1162
2024
Q4
$51.1M Buy
2,062,246
+566,051
+38% +$14.4M 0.01% 1254
2024
Q3
$36.7M Buy
1,496,195
+727,041
+95% +$18.8M 0.01% 1505
2024
Q2
$18M Buy
769,154
+729,641
+1,847% +$17.9M ﹤0.01% 2099
2024
Q1
$1.31M Buy
39,513
+28,068
+245% +$874K ﹤0.01% 6384
2023
Q4
$312K Sell
11,445
-1,165,470
-99% -$29M ﹤0.01% 9091
2023
Q3
$28.3M Buy
1,176,915
+857,371
+268% +$23M 0.01% 1550
2023
Q2
$10.2M Buy
319,544
+138,344
+76% +$4.49M ﹤0.01% 2648
2023
Q1
$5.55M Buy
181,200
+51,938
+40% +$2.05M ﹤0.01% 3635
2022
Q4
$5.06M Buy
129,262
+34,930
+37% +$1.56M ﹤0.01% 3839
2022
Q3
$4.49M Buy
94,332
+41,000
+77% +$2.34M ﹤0.01% 4058
2022
Q2
$2.06M Sell
53,332
-111,186
-68% -$4.42M ﹤0.01% 5485
2022
Q1
$9.43M Buy
164,518
+83,789
+104% +$5.5M ﹤0.01% 3038
2021
Q4
$6.43M Sell
80,729
-135,463
-63% -$11.6M ﹤0.01% 3857
2021
Q3
$18.8M Buy
216,192
+194,580
+900% +$19.5M ﹤0.01% 2091
2021
Q2
$2.78M Sell
21,612
-135,705
-86% -$10.8M ﹤0.01% 5787
2021
Q1
$12.6M Buy
157,317
+147,684
+1,533% +$14M ﹤0.01% 2637
2020
Q4
$786K Buy
+9,633
New +$474K ﹤0.01% 7289
2020
Q3
Sell
-27,126
Closed -$759K 10064
2020
Q2
$759K Sell
27,126
-59,173
-69% -$1.28M ﹤0.01% 6340
2020
Q1
$1.55M Buy
+86,299
New +$1.88M ﹤0.01% 4554

Other funds holding BEAM